ZNF252P-AS1 enhances myeloid-derived suppressor cell expansion and tumor glycolysis to accelerate laryngeal squamous cell carcinoma development via the miR-377-3p/ lactate dehydrogenase a axis

ConclusionOur results indicated that ZNF252P-AS1 was important in LSCC development, and has been identified as an oncogenic promoter, making it a potential therapeutic target for LSCC therapy.
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research